UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000025685
Receipt number R000027922
Scientific Title Effects of Misatol GL , a heat-concentrated extract from Japanese green apricot, in patients with non-alcoholic fatty liver disease / non-alcoholic steatohepatitis -Multicenter trial-
Date of disclosure of the study information 2017/01/15
Last modified on 2020/01/22 16:17:48

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effects of Misatol GL , a heat-concentrated extract from Japanese green apricot, in patients with non-alcoholic fatty liver disease / non-alcoholic steatohepatitis -Multicenter trial-

Acronym

Effects of Japanese apricot extract (Misatol GL) in patients with NAFLD /NASH

Scientific Title

Effects of Misatol GL , a heat-concentrated extract from Japanese green apricot, in patients with non-alcoholic fatty liver disease / non-alcoholic steatohepatitis -Multicenter trial-

Scientific Title:Acronym

Effects of Japanese apricot extract (Misatol GL) in patients with NAFLD /NASH

Region

Japan


Condition

Condition

NAFLD/NASH

Classification by specialty

Hepato-biliary-pancreatic medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The aim of this study is to examine the effects of Misatol GL on serum ALT in patients with NAFLD /NASH

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Change in serum ALT

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation

YES

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

Misatol GL twice (6.5g x 2) per day for 8 weeks

Interventions/Control_2

Placebo twice (6.5g x 2) per day for 8 weeks

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

75 years-old >

Gender

Male and Female

Key inclusion criteria

1. Patients with hepatic steatosis is suspected by abdominal US, CT or MRI tests.
2. ALT higher than 60 IU/L
3. Patients who are able to provide written informed consent.

Key exclusion criteria

1. Patients who have serious liver disease (decompensated cirrhosis (Child-Pugh B<), liver cancer), whose ALT higher than 300 IU/L, or jaundice.
2. Other chronic liver disease (alcoholic liver disease, virus hepatitis, autoimmune hepatitis, metabolic liver disease)
3. Patients who have undergone bariatric surgery.
4. Pregnant woman, lactating woman, or a woman suspected of pregnancy.
5. Patients under insulin treatment.
6. Patients with severe cardiac disease.
7. Patients with severe kidney disease (CRE>2.0 mg/dL).
8. Patients who are unable to comply with administrative matters.
9. Patients who are allergic to the test foods.
10. Patients who have alcohol intake more than 30 g/day for male, and more than 20 g/day for female.
11. Patients who have participated in a clinical trials in the last 3 months.
12. Patients who are currently taking Misatol.
13. Patients who are judged by the investigator not to be appropriate for inclusion in the study.

Target sample size

120


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Mikio Zeniya

Organization

Sanno Medical Center

Division name

Department of Internal Medicine

Zip code


Address

8-5-35, Akasaka, Minato-ku, Tokyo, 105-0003, Japan

TEL

03-3402-5581

Email

zeniya@iuhw.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Shiro Ueda

Organization

Medical Edge Inc.

Division name

Sytem Development

Zip code


Address

2-12-8, Shinjuku, Shinjuku-ku, Tokyo, 160-0022, Japan

TEL

03-4400-7070

Homepage URL


Email

system-info@medicaledge.jp


Sponsor or person

Institute

Sanno Medical Center

Institute

Department

Personal name



Funding Source

Organization

Otsuka Pharmaceutical Factory, Inc.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor

1.Jntenndo University Hospital
2.The Jikei University Daisan Hospital
3.Tokyo Metropolitan Bokutoh Hospital
4.Kyoundo Hospital
5. Chiba University Hospital
6.Kitaibaraki City Hospital
7.Shibata Hepatology Clinic
8.Toshima Hospital

Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 01 Month 15 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2016 Year 08 Month 18 Day

Date of IRB

2016 Year 07 Month 25 Day

Anticipated trial start date

2017 Year 01 Month 12 Day

Last follow-up date

2019 Year 04 Month 30 Day

Date of closure to data entry

2019 Year 08 Month 22 Day

Date trial data considered complete

2019 Year 08 Month 22 Day

Date analysis concluded

2020 Year 12 Month 09 Day


Other

Other related information



Management information

Registered date

2017 Year 01 Month 15 Day

Last modified on

2020 Year 01 Month 22 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000027922


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name